Imatinib Mesylate Tablets are prescribed for treatment of cancer specifically CML, CLL, and certain types of gastrointestinal stromal tumors. They are anti-neoplastic agents that are considered as tyrosine kinase inhibitors that prevent phosphorylation and activation of growth receptors. Active compound of these tablets has molecular formula C30H35N7O4 with molar mass of 589.715 g/mol. They are known to show bioavailability of 98% with 95% of protein binding ability. Active chemical in these tablets go and bind to active site of tyrosine kinase and decrease its activity. Upon absorption in body, Imatinib Mesylate Tablets get metabolized in liver with help of CYP3A4 and has elimination half life of about 40 hours.
|Packaging Size||30 Tablets|
Imatinib Tablets supplier, Imatinib Tablets manufacturer in India,
ACTIZA PHARMACEUTICAL All Rights Reserved.